Works matching IS 0008543X AND DT 2024 AND VI 130 AND IP 8

Results: 20
    1

    Issue Information.

    Published in:
    Cancer (0008543X), 2024, v. 130, n. 8, p. 1359, doi. 10.1002/cncr.34293
    Publication type:
    Article
    2
    3

    Incidence of blast phase in myelofibrosis patients according to anemia severity at ruxolitinib start and during therapy.

    Published in:
    Cancer (0008543X), 2024, v. 130, n. 8, p. 1270, doi. 10.1002/cncr.35156
    By:
    • Palandri, Francesca;
    • Palumbo, Giuseppe A.;
    • Benevolo, Giulia;
    • Iurlo, Alessandra;
    • Elli, Elena M.;
    • Abruzzese, Elisabetta;
    • Polverelli, Nicola;
    • Tiribelli, Mario;
    • Auteri, Giuseppe;
    • Tieghi, Alessia;
    • Caocci, Giovanni;
    • Binotto, Gianni;
    • Cavazzini, Francesco;
    • Branzanti, Filippo;
    • Beggiato, Eloise;
    • Miglino, Maurizio;
    • Bosi, Costanza;
    • Crugnola, Monica;
    • Bocchia, Monica;
    • Martino, Bruno
    Publication type:
    Article
    4
    5

    Lung cancer statistics, 2023.

    Published in:
    Cancer (0008543X), 2024, v. 130, n. 8, p. 1330, doi. 10.1002/cncr.35128
    By:
    • Kratzer, Tyler B.;
    • Bandi, Priti;
    • Freedman, Neal D.;
    • Smith, Robert A.;
    • Travis, William D.;
    • Jemal, Ahmedin;
    • Siegel, Rebecca L.
    Publication type:
    Article
    6
    7

    Identification of novel prognostic autoantibodies in diffuse large B‐cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone via a high‐throughput antigen microarray.

    Published in:
    Cancer (0008543X), 2024, v. 130, n. 8, p. 1257, doi. 10.1002/cncr.35158
    By:
    • Dai, Liyuan;
    • Chen, Haizhu;
    • Tan, Qiaoyun;
    • Wang, Yanrong;
    • Li, Lin;
    • Lou, Ning;
    • Fan, Guangyu;
    • Xie, Tongji;
    • Luo, Rongrong;
    • Wang, Shasha;
    • Zhou, Yu;
    • Zhong, Qiaofeng;
    • Yao, Jiarui;
    • Zhang, Zhishang;
    • Tang, Le;
    • Shi, Yuankai;
    • Han, Xiaohong
    Publication type:
    Article
    8
    9
    10

    Validation of the RSClin risk calculator in the National Cancer Data Base.

    Published in:
    Cancer (0008543X), 2024, v. 130, n. 8, p. 1210, doi. 10.1002/cncr.35163
    By:
    • Vannier, Augustin G. L.;
    • Dhungana, Asim;
    • Zhao, Fangyuan;
    • Chen, Nan;
    • Shubeck, Sarah;
    • Hahn, Olwen M.;
    • Nanda, Rita;
    • Jaskowiak, Nora T.;
    • Fleming, Gini F.;
    • Olopade, Olufunmilayo I.;
    • Pearson, Alexander T.;
    • Huo, Dezheng;
    • Howard, Frederick M.
    Publication type:
    Article
    11
    12
    13

    The genetic landscape of histologically transformed marginal zone lymphomas.

    Published in:
    Cancer (0008543X), 2024, v. 130, n. 8, p. 1246, doi. 10.1002/cncr.35072
    By:
    • Li, Anqi;
    • Yi, Hongmei;
    • Deng, Shijie;
    • Ruan, Miao;
    • Xu, Pengpeng;
    • Huo, Yujia;
    • Lu, Haiyang;
    • Shen, Xia;
    • Ouyang, Binsen;
    • Cai, Mingci;
    • Xu, Haimin;
    • Wang, Zhongyu;
    • Zhang, Lei;
    • Zhu, Lingyan;
    • Peng, Qi;
    • Gu, Yijin;
    • Xie, Jialing;
    • Wang, Yan;
    • Dong, Lei;
    • Liu, Zebing
    Publication type:
    Article
    14
    15

    Issue Information.

    Published in:
    Cancer (0008543X), 2024, v. 130, n. 8, p. 1183, doi. 10.1002/cncr.34293
    Publication type:
    Article
    16
    17

    NRG‐GY012: Randomized phase 2 study comparing olaparib, cediranib, and the combination of cediranib/olaparib in women with recurrent, persistent, or metastatic endometrial cancer.

    Published in:
    Cancer (0008543X), 2024, v. 130, n. 8, p. 1234, doi. 10.1002/cncr.35151
    By:
    • Rimel, Bobbie J.;
    • Enserro, Danielle;
    • Bender, David P.;
    • Jackson, Camille Gunderson;
    • Tan, Annie;
    • Alluri, Nitya;
    • Borowsky, Mark;
    • Moroney, John;
    • Hendrickson, Andrea Wahner;
    • Backes, Floor;
    • Swisher, Elizabeth;
    • Powell, Matthew;
    • MacKay, Helen
    Publication type:
    Article
    18

    The cumulative burden of self‐reported, clinically relevant outcomes in long‐term childhood cancer survivors and implications for survivorship care: A DCCSS LATER study.

    Published in:
    Cancer (0008543X), 2024, v. 130, n. 8, p. 1349, doi. 10.1002/cncr.35148
    By:
    • Streefkerk, Nina;
    • Teepen, Jop C.;
    • Feijen, Elizabeth A. M.;
    • Jóźwiak, Katarzyna;
    • van der Pal, Helena J. H.;
    • Ronckers, Cecile M.;
    • De Vries, Andrica C. H.;
    • Van der Heiden‐van Der Loo, Margriet;
    • Hollema, Nynke;
    • van den Berg, Marleen;
    • Loonen, Jacqueline;
    • Grootenhuis, Martha A.;
    • Bresters, Dorine;
    • Versluys, A. Brigitta;
    • van Dulmen‐den Broeder, Eline;
    • van den Heuvel‐Eibrink, Marry M.;
    • van Leeuwen, Flora E.;
    • Neggers, Sebastian J. C. M. M.;
    • Van Santen, Hanneke M.;
    • Hawkins, Mike
    Publication type:
    Article
    19

    A call to action to advance patient‐focused and decentralized clinical trials.

    Published in:
    Cancer (0008543X), 2024, v. 130, n. 8, p. 1193, doi. 10.1002/cncr.35145
    By:
    • Harvey, R. Donald;
    • Miller, Therica M.;
    • Hurley, Patricia A.;
    • Thota, Ramya;
    • Black, Lora J.;
    • Bruinooge, Suanna S.;
    • Boehmer, Leigh M.;
    • Fleury, Mark E.;
    • Kamboj, Jasmine;
    • Rizvi, Mujahid A.;
    • Symington, Banu E.;
    • Tap, William D.;
    • Waterhouse, David M.;
    • Levit, Laura A.;
    • Merrill, Janette K.;
    • Prindiville, Sheila A.;
    • Pollastro, Teri;
    • Brewer, Jamie R.;
    • Byatt, Leslie P.;
    • Hamroun, Leila
    Publication type:
    Article
    20